Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis.

Psoriasis vulgaris pharmacological mechanisms randomized controlled trials traditional Chinese medicine

Journal

The Journal of dermatological treatment
ISSN: 1471-1753
Titre abrégé: J Dermatolog Treat
Pays: England
ID NLM: 8918133

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 2 7 2020
medline: 8 4 2022
entrez: 2 7 2020
Statut: ppublish

Résumé

Psoriasis vulgaris (PV) not only affects patients' skin health but also increases the risk of coronary heart disease and diabetes, which brings both physical and mental harms. Its pathogenesis is complex, and the multitarget effect of traditional Chinese medicine (TCM) is especially advantageous. Because a considerable number of randomized controlled trials related to TCM exhibit design defects, small sample size, or inadequate intervention time, so the status of TCM in the treatment of PV cannot be fully clarified. We reviewed the controlled clinical trials published over the past decade and selected 17 high-quality articles from over 2000 papers. The results suggest that TCM might be beneficial for decrease in PASI scores, thus, TCM might be an effective alternative therapy for PV management. The safety of TCM on PV was also assessed in our analysis. The more strictly designed and long-term observations of TCM for PV are supposed to be conducted in the future.

Identifiants

pubmed: 32610023
doi: 10.1080/09546634.2020.1789048
doi:

Substances chimiques

Drugs, Chinese Herbal 0

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-681

Auteurs

Dan Dai (D)

Department of Dermatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing China.
Graduate College, Beijing University of Chinese Medicine, Beijing, China.

Haoran Wu (H)

Graduate College, Beijing University of Chinese Medicine, Beijing, China.
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Chunyan He (C)

Department of Dermatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing China.
Graduate College, Beijing University of Chinese Medicine, Beijing, China.

Xinmiao Wang (X)

Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Yiqi Luo (Y)

Graduate College, Beijing University of Chinese Medicine, Beijing, China.

Ping Song (P)

Department of Dermatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH